272 related articles for article (PubMed ID: 34588861)
21. How Hepatitis C Virus Leads to Hepatocellular Carcinoma: A Network-Based Study.
Poortahmasebi V; Poorebrahim M; Najafi S; Jazayeri SM; Alavian SM; Arab SS; Ghavami S; Alavian SE; Rezaei Moghadam A; Amiri M
Hepat Mon; 2016 Feb; 16(2):e36005. PubMed ID: 27148389
[TBL] [Abstract][Full Text] [Related]
22. Screening of potential biomarkers in hepatitis C virus-induced hepatocellular carcinoma using bioinformatic analysis.
Liu J; Ma Z; Liu Y; Wu L; Hou Z; Li W
Oncol Lett; 2019 Sep; 18(3):2500-2508. PubMed ID: 31452738
[TBL] [Abstract][Full Text] [Related]
23. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
[TBL] [Abstract][Full Text] [Related]
24. Identification of potential miRNA-mRNA regulatory network contributing to pathogenesis of HBV-related HCC.
Lou W; Liu J; Ding B; Chen D; Xu L; Ding J; Jiang D; Zhou L; Zheng S; Fan W
J Transl Med; 2019 Jan; 17(1):7. PubMed ID: 30602391
[TBL] [Abstract][Full Text] [Related]
25. Identification of Hub Genes in Type 2 Diabetes Mellitus Using Bioinformatics Analysis.
Lin Y; Li J; Wu D; Wang F; Fang Z; Shen G
Diabetes Metab Syndr Obes; 2020; 13():1793-1801. PubMed ID: 32547141
[TBL] [Abstract][Full Text] [Related]
26. Identification of hub genes and biological pathways in hepatocellular carcinoma by integrated bioinformatics analysis.
Zhao Q; Zhang Y; Shao S; Sun Y; Lin Z
PeerJ; 2021; 9():e10594. PubMed ID: 33552715
[TBL] [Abstract][Full Text] [Related]
27. Identification of Tissue-Specific Expressed Hub Genes and Potential Drugs in Rheumatoid Arthritis Using Bioinformatics Analysis.
Xing X; Xia Q; Gong B; Shen Z; Zhang Y
Front Genet; 2022; 13():855557. PubMed ID: 35368701
[No Abstract] [Full Text] [Related]
28. Integrative bioinformatics approaches to map key biological markers and therapeutic drugs in Extramammary Paget's disease of the scrotum.
Noor F; Saleem MH; Chen JT; Javed MR; Al-Megrin WA; Aslam S
PLoS One; 2021; 16(7):e0254678. PubMed ID: 34292991
[TBL] [Abstract][Full Text] [Related]
29. Analysis of potential key genes in very early hepatocellular carcinoma.
Wu M; Liu Z; Li X; Zhang A; Lin D; Li N
World J Surg Oncol; 2019 May; 17(1):77. PubMed ID: 31043166
[TBL] [Abstract][Full Text] [Related]
30. Bioinformatics analysis reveals meaningful markers and outcome predictors in HBV-associated hepatocellular carcinoma.
Zhang L; Makamure J; Zhao D; Liu Y; Guo X; Zheng C; Liang B
Exp Ther Med; 2020 Jul; 20(1):427-435. PubMed ID: 32537007
[TBL] [Abstract][Full Text] [Related]
31. Identification of core genes and outcomes in hepatocellular carcinoma by bioinformatics analysis.
Shen S; Kong J; Qiu Y; Yang X; Wang W; Yan L
J Cell Biochem; 2019 Jun; 120(6):10069-10081. PubMed ID: 30525236
[TBL] [Abstract][Full Text] [Related]
32. Identification of potential hub genes related to the progression and prognosis of hepatocellular carcinoma through integrated bioinformatics analysis.
Song X; Du R; Gui H; Zhou M; Zhong W; Mao C; Ma J
Oncol Rep; 2020 Jan; 43(1):133-146. PubMed ID: 31746405
[TBL] [Abstract][Full Text] [Related]
33. Identification of the critical genes and miRNAs in hepatocellular carcinoma by integrated bioinformatics analysis.
Wang J; Wang C; Yang L; Li K
Med Oncol; 2022 Jan; 39(2):21. PubMed ID: 34982264
[TBL] [Abstract][Full Text] [Related]
34. Identification of potential hub genes associated with the pathogenesis and prognosis of hepatocellular carcinoma via integrated bioinformatics analysis.
Meng Z; Wu J; Liu X; Zhou W; Ni M; Liu S; Guo S; Jia S; Zhang J
J Int Med Res; 2020 Jul; 48(7):300060520910019. PubMed ID: 32722976
[TBL] [Abstract][Full Text] [Related]
35. Differences of core genes in liver fibrosis and hepatocellular carcinoma: Evidence from integrated bioinformatics and immunohistochemical analysis.
Li Y; Yuan SL; Yin JY; Yang K; Zhou XG; Xie W; Wang Q
World J Gastrointest Oncol; 2022 Jul; 14(7):1265-1280. PubMed ID: 36051101
[TBL] [Abstract][Full Text] [Related]
36. The genetic association between type 2 diabetic and hepatocellular carcinomas.
Shi Z; Xiao Z; Hu L; Gao Y; Zhao J; Liu Y; Shen G; Xu Q; Huang D
Ann Transl Med; 2020 Mar; 8(6):380. PubMed ID: 32355824
[TBL] [Abstract][Full Text] [Related]
37. Identification of metabolism genes related to hepatocarcinogenesis and progression in type 2 diabetes mellitus via co-expression networks analysis.
Bi Y; Yin B; Fan G
Hereditas; 2021 Apr; 158(1):14. PubMed ID: 33865459
[TBL] [Abstract][Full Text] [Related]
38. Bioinformatics analysis of molecular genetic targets and key pathways for hepatocellular carcinoma.
Tu J; Chen J; He M; Tong H; Liu H; Zhou B; Liao Y; Wang Z
Onco Targets Ther; 2019; 12():5153-5162. PubMed ID: 31303768
[TBL] [Abstract][Full Text] [Related]
39. Identification of key genes, pathways and potential therapeutic agents for liver fibrosis using an integrated bioinformatics analysis.
Zhan Z; Chen Y; Duan Y; Li L; Mew K; Hu P; Ren H; Peng M
PeerJ; 2019; 7():e6645. PubMed ID: 30923657
[TBL] [Abstract][Full Text] [Related]
40. Bioinformatic Analysis Combined With Experimental Validation Reveals Novel Hub Genes and Pathways Associated With Focal Segmental Glomerulosclerosis.
Hou YP; Diao TT; Xu ZH; Mao XY; Wang C; Li B
Front Mol Biosci; 2021; 8():691966. PubMed ID: 35059432
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
